GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » Altman Z2-Score

SFES (Safeguard Scientifics) Altman Z2-Score : -98.03 (As of Apr. 04, 2025)


View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics Altman Z2-Score?

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

Safeguard Scientifics has a Altman Z2-Score of -98.03, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Safeguard Scientifics's Altman Z2-Score or its related term are showing as below:


Safeguard Scientifics Altman Z2-Score Historical Data

The historical data trend for Safeguard Scientifics's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safeguard Scientifics Altman Z2-Score Chart

Safeguard Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.92 -26.53 -20.66 -50.09 -98.03

Safeguard Scientifics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.09 -54.70 -63.41 -59.91 -98.03

Competitive Comparison of Safeguard Scientifics's Altman Z2-Score

For the Asset Management subindustry, Safeguard Scientifics's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Safeguard Scientifics's Altman Z2-Score Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Safeguard Scientifics's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Safeguard Scientifics's Altman Z2-Score falls into.


;
;

Safeguard Scientifics Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Safeguard Scientifics's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.3444+3.26*-32.1302+6.72*-0.4304+1.05*6.9958
=-98.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $22.84 Mil.
Total Current Assets was $9.91 Mil.
Total Current Liabilities was $2.05 Mil.
Retained Earnings was $-733.73 Mil.
Pre-Tax Income was -4.414 + 0.932 + -2.862 + -3.484 = $-9.83 Mil.
Interest Expense was 0 + 0 + 0 + 0 = $0.00 Mil.
Total Liabilities was $2.86 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(9.911 - 2.046)/22.836
=0.3444

X2=Retained Earnings/Total Assets
=-733.726/22.836
=-32.1302

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-9.828 - 0)/22.836
=-0.4304

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(19.98 - 0)/2.856
=6.9958

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Safeguard Scientifics has a Altman Z2-Score of -98.03 indicating it is in Distress Zones.


Safeguard Scientifics  (OTCPK:SFES) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Safeguard Scientifics Altman Z2-Score Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's Altman Z2-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Safeguard Scientifics Business Description

Traded in Other Exchanges
N/A
Address
150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087
Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. It generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, it focuses on pursuing monetization opportunities to return value to shareholders.
Executives
Satterfield Thomas A Jr 10 percent owner 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont director 51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr. director 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Mark Herndon officer: SVP & Chief Financial Officer C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman officer: Chief Restructuring Officer C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert director C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts director 1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko officer: Senior V.P. & General Counsel 435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass director 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille officer: Senior VP & CFO C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison director C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli officer: Acting Sr VP & Acting CFO FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz director P O BOX 738, RYE NH 03870